Biotechnology Stocks I Performance Guide: Phathom Pharmaceuticals, Inc. (PHAT)
PHAT has no dividends.
Table and Chart of PHAT Performance
See what a $1,000 investment in PHAT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PHAT Returns | |
|---|---|
| Start Date | Nov-29-2019 |
| Start Price | $25.60 |
| End Date | Oct-11-2024 |
| End Price | $15.09 |
| # Prices | 60 |
| Min Date | Jan-31-2024 |
| Min Price | $6.70 |
| Max Date | Feb-26-2021 |
| Max Price | $44.05 |
| Total Return | -41.05% |
| Annualized Return | -10.03% |
| Current Value of $1,000 Purchase | $589 |
| Number Returns | 1,770 |
| Average Return | -30.05% |
| Number Profitable Returns | 440 |
| Percent Profitable Returns | 24.86% |
| Number Unprofitable Returns | 1,330 |
| Percent Unprofitable Returns | 75.14% |
| Profitable to Unprofitable Returns Ratio | 0.33 |
| PHAT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -2.204 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -252071008 |
| PE to Growth Ratio | None |
| Price to Book | 108.1 |
| PRICE DATA | |
| 52 Week High | $0.711 |
| 52 Week Low | $19.71 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $6.07 |
| 200-Day Moving Average | $15.66 |
| FINANCIAL DATA | |
| Revenue per Share | $-5.18 |
| Revenue | $-35 |
| Profit Margin | 17.2% |
| Return on Equity | -54.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PHAT Compare Returns with S&P 500
PHAT Trendline Chart
PHAT Moving Average Chart
PHAT Stock Return Map - See Patterns of Gains and Losses
PHAT Stock Returns/Purchase Dates